首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1498663

全球球囊瓣膜成形術設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Balloon Valvuloplasty Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球球囊瓣膜成形術設備市場需求預計將從 2023 年的 29.7 億美元達到近 47.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 5.36%。

球囊瓣膜成形術裝置是用於治療狹窄心臟瓣膜的醫療工具，通常用於擴大狹窄的心臟瓣膜（例如主動脈瓣或二尖瓣）的手術。此過程需要將帶有球囊的導管穿過血管到達受影響的瓣膜。一旦就位，球囊就會膨脹以擴大瓣膜開口，改善血流並減輕症狀。球囊瓣膜成形術是瓣膜置換手術的一種微創替代手術，可為某些患者提供更短的恢復時間並降低風險。它通常用於兒科心臟病學以及不適合心臟直視手術的患者。

市場動態

由於人口老化和心血管危險因子發病率的不斷上升，主動脈瓣狹窄和二尖瓣關閉不全等瓣膜性心臟病的盛行率不斷上升，推動了球囊瓣膜成形術設備市場的發展，推動了市場對球囊瓣膜成形術等微創治療方案的需求。這種日益嚴重的疾病負擔強調需要有效且侵入性較小的手術干預替代方案，從而推動市場成長。球囊瓣膜成形術設備的技術進步，包括下一代導管和輸送系統的開發，提高了手術成功率和患者結果，並推動了更廣泛的臨床環境的採用。將球囊瓣膜成形術的適應症從傳統的高風險手術患者擴展到低風險族群和老年人群，進一步擴大了市場範圍和潛力。此外，增加醫療保健支出和對心血管護理基礎設施的投資，特別是在新興經濟體，透過擴大球囊瓣膜成形術等先進治療方式的可及性，有助於市場成長。此外，旨在促進市場准入並確保患者安全和護理品質的支持性報銷政策和監管框架刺激了對球囊瓣膜成形術設備的市場需求。然而，潛在的併發症和手術的高成本可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球球囊瓣膜成形術設備市場的每個細分市場進行了包容性評估。球囊瓣膜成形術設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

球囊瓣膜成形術設備市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

依產品類型

標準氣球
切割氣球
得分氣球
高壓氣球
低壓氣球

按申請

主動脈瓣狹窄
肺動脈瓣狹窄

按年齡段

兒科
成人

按最終用途

醫院
門診手術中心
專科診所
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的球囊瓣膜成形術設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。球囊瓣膜成形術設備市場的主要參與者包括Abbott Laboratories、B. Braun Melsungen AG、Becton、Dickinson, Company、Boston Scientific Corporation、Cardinal Health Inc.、Cook Medical Inc.、Edwards Lifesciences Corporation、Innomed Medical Development Ltd. 、Jotech GmbH、Medtronic Plc、Microport Scientific Corporation、Numed Canada Inc.、NuMED Inc.、Osypka Medical GmbH、Teleflex Incorporated。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 市場吸引力分析：按產品類型
- 市場吸引力分析：依應用分類
- 按年齡層別分類的市場吸引力分析
- 按最終用途分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球氣球瓣膜成形術設備市場分析：依產品類型

概述：按產品類型
歷史與預測資料分析：按產品類型
標準氣球
切割氣球
得分氣球
高壓氣球
低壓氣球

第 6 章：全球氣球瓣膜成形術設備市場分析：依應用分類

概述：按應用
歷史與預測資料分析：按應用分類
主動脈瓣狹窄
肺動脈瓣狹窄

第 7 章：全球氣球瓣膜成形術設備市場分析：依年齡層

按年齡層別概述
按年齡層別進行的歷史和預測資料分析
兒科
成人

第 8 章：全球氣球瓣膜成形術設備市場分析：依最終用途分類

按最終用途分類的概述
按最終用途分類的歷史和預測資料分析
醫院
門診手術中心
專科診所
其他

第 9 章：全球氣球瓣膜成形術設備市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：球囊瓣膜成形術設備公司的競爭格局

球囊瓣膜成形術設備市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Abbott Laboratories

公司簡介
公司收入
產品
最近的發展

B. Braun Melsungen AG

公司簡介
公司收入
產品
最近的發展

Becton, Dickinson Company

公司簡介
公司收入
產品
最近的發展

NuMED Inc.

公司簡介
公司收入
產品
最近的發展

Osypka Medical GmbH

公司簡介
公司收入
產品
最近的發展

Boston Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Cardinal Health Inc.

公司簡介
公司收入
產品
最近的發展

Cook Medical Inc.

公司簡介
公司收入
產品
最近的發展

Edwards Lifesciences Corporation

公司簡介
公司收入
產品
最近的發展

Innomed Medical Development Ltd.

公司簡介
公司收入
產品
最近的發展

Jotech GmbH

公司簡介
公司收入
產品
最近的發展

Medtronic Plc

公司簡介
公司收入
產品
最近的發展

Microport Scientific Corporation

公司簡介
公司收入
產品
最近的發展

Numed Canada Inc.

公司簡介
公司收入
產品
最近的發展

Teleflex Incorporated

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114760

The global demand for Balloon Valvuloplasty Devices Market is presumed to reach the market size of nearly USD 4.75 Billion by 2032 from USD 2.97 Billion in 2023 with a CAGR of 5.36% under the study period 2024-2032.

Balloon valvuloplasty devices are medical tools used to treat stenotic heart valves, typically in procedures to widen narrowed heart valves, such as the aortic or mitral valves. The process entails threading a catheter with an attached balloon through the blood vessels to the affected valve. Once in place, the balloon is inflated to enlarge the valve opening, improving blood flow and reducing symptoms. Balloon valvuloplasty is a minimally invasive alternative to valve replacement surgery, offering shorter recovery times and reduced risks for certain patients. It is commonly used in pediatric cardiology and for patients not candidates for open-heart surgery.

MARKET DYNAMICS

The balloon valvuloplasty devices market is driven by the increasing prevalence of valvular heart diseases, such as aortic stenosis and mitral regurgitation, due to aging populations and the escalating incidence of cardiovascular risk factors, drives market demand for minimally invasive treatment options like balloon valvuloplasty. This growing disease burden underscores the need for effective & less invasive alternatives to surgical interventions, fuelling market growth. Technological advancements in balloon valvuloplasty devices, including the development of next-generation catheters and delivery systems, enhance procedural success rates and patient outcomes, driving adoption across a wider range of clinical settings. Expanding indications for balloon valvuloplasty beyond traditional high-risk surgical patients to include lower-risk and elderly populations further broadens the market's scope and potential. Moreover, increasing healthcare expenditure and investments in cardiovascular care infrastructure, particularly in emerging economies, contribute to market growth by expanding access to advanced treatment modalities like balloon valvuloplasty. Furthermore, supportive reimbursement policies and regulatory frameworks aimed at facilitating market access and ensuring patient safety and quality of care stimulate market demand for balloon valvuloplasty devices. However, potential complications and the high cost of the procedure may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Balloon Valvuloplasty Devices. The growth and trends of Balloon Valvuloplasty Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Balloon Valvuloplasty Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Standard Balloon
Cutting Balloon
Scoring Balloon
High-Pressure Balloon
Low-Pressure Balloon

By Application

Aortic Valve Stenosis
Pulmonary Valve Stenosis

By Age Group

Pediatric
Adult

By End-use

Hospitals
Ambulatory Surgical Centres
Specialty Clinics
Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Balloon Valvuloplasty Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Balloon Valvuloplasty Devices market include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson, Company, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Innomed Medical Development Ltd., Jotech GmbH, Medtronic Plc, Microport Scientific Corporation, Numed Canada Inc., NuMED Inc., Osypka Medical GmbH, Teleflex Incorporated. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BALLOON VALVULOPLASTY DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Age Group
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data Analysis By Product Type
5.3. Standard Balloon Historic and Forecast Sales By Regions
5.4. Cutting Balloon Historic and Forecast Sales By Regions
5.5. Scoring Balloon Historic and Forecast Sales By Regions
5.6. High-Pressure Balloon Historic and Forecast Sales By Regions
5.7. Low-Pressure Balloon Historic and Forecast Sales By Regions

6. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Aortic Valve Stenosis Historic and Forecast Sales By Regions
6.4. Pulmonary Valve Stenosis Historic and Forecast Sales By Regions

7. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY AGE GROUP

7.1. Overview By Age Group
7.2. Historical and Forecast Data Analysis By Age Group
7.3. Pediatric Historic and Forecast Sales By Regions
7.4. Adult Historic and Forecast Sales By Regions

8. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data Analysis By End-use
8.3. Hospitals Historic and Forecast Sales By Regions
8.4. Ambulatory Surgical Centres Historic and Forecast Sales By Regions
8.5. Specialty Clinics Historic and Forecast Sales By Regions
8.6. Other Historic and Forecast Sales By Regions

9. GLOBAL BALLOON VALVULOPLASTY DEVICES MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BALLOON VALVULOPLASTY DEVICES COMPANIES

10.1. Balloon Valvuloplasty Devices Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF BALLOON VALVULOPLASTY DEVICES INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Abbott Laboratories
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. B. Braun Melsungen AG
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Becton, Dickinson Company
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. NuMED Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Osypka Medical GmbH
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Boston Scientific Corporation
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Cardinal Health Inc.
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Cook Medical Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Edwards Lifesciences Corporation
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Innomed Medical Development Ltd.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Jotech GmbH
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Medtronic Plc
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Microport Scientific Corporation
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. Numed Canada Inc.
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
11.17. Teleflex Incorporated
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments